Compare CVS Health Corp (CVS) vs Alphabet Inc Class A (GOOGL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Alphabet Inc Class A — how do they compare? CVS Health Corp trades at $93.5 (market cap $119.58B), while Alphabet Inc Class A trades at $345.53 (market cap $4.20T). The key difference: Alphabet Inc Class A is far larger — about 35.1× CVS Health Corp's market cap, and CVS Health Corp pays the higher dividend (2.84%). Which is the better fit depends on your goals.
| CVS | GOOGL | |
|---|---|---|
Market Cap | $119.58B | $4.20T |
Sector | Health | Media |
52-Week High | $110.60 | $402.62 |
52-Week Low | $65.51 | $199.32 |
Enterprise Value | $181.93B | $4.09T |
Dividend Yield | 2.84% | 0.26% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $95.67, down slightly by 0.03% today. The stock shows strong fundamental momentum with recent quarterly earnings beats, including Q2 2026 EPS of $2.58 versus $1.87 expected, and raised 2026 guidance. Valuation metrics appear reasonable with a P/E of 24.67 and P/S of 0.29. Technical indicators are mixed with a bullish overall signal but bearish moving averages, with key support at $95 and resistance at $96.
The outlook for CVS is positive, supported by earnings strength and analyst consensus, but risks include margin pressure and rising debt levels. The consensus price target of $115.90 implies significant upside, though investors should monitor execution on guidance and healthcare regulatory changes.
Alphabet (GOOGL) trades at $357.52, up 0.91% today, with a bullish technical signal from moving averages and strong support at $354. The stock shows robust fundamentals, with revenue growing from $350.0B in 2024 to $402.8B in 2025 (SEC filings, 2025), net income margin expanding to 32.8%, and consistent earnings beats. Recent news highlights AI-driven growth opportunities, including partnerships and YouTube price increases (Reuters, 2026-04-10).
Outlook remains positive with an 85% analyst buy rating and $426.28 consensus price target (MarketBeat, 2026-04-11), though risks include antitrust scrutiny and tech sector volatility. Earnings growth and AI integration are key catalysts for upside, while competition and regulatory pressures warrant monitoring.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Alphabet Inc Class A
Alphabet, the parent company of Google, earns nearly 90% of its revenue from Google services, mainly through advertising. Other revenue comes from subscriptions (YouTube TV, YouTube Music), platform sales (Play Store purchases), and devices (Pixel, Chromebooks, Chromecast). Google Cloud contributes around 10%, while investments in self-driving cars (Waymo), health (Verily), and internet access (Google Fiber) make up the rest.
Read more on GOOGL →
